Vacation Tummy Ache—Four Days Later, Tragedy

The family thought it was a simple stomach ache on vacation; four days later, their 5-year-old son was gone from a disease most doctors will never see once in their careers.

Story Snapshot

A healthy 5-year-old boy, Justin Vu, fell ill mid-vacation and died within days from Clarkson’s disease.
The family’s Oregon trip went from beach photos to a frantic fight for life in a children’s hospital.
Clarkson’s disease, a form of systemic capillary leak syndrome, has only a few hundred known cases worldwide.
This tragedy shows how rare diseases quietly threaten families despite almost zero public awareness.

A family vacation that turned into a medical nightmare

Five-year-old Justin Vu arrived in the Pacific Northwest with his parents, Therese Peden and Viet Vu, for what was supposed to be a simple summer vacation. They visited Cannon Beach, played at the Oregon coast, and enjoyed the Oregon Zoo. In every photo and memory from those first days, Justin looks like what he was described as by his parents: healthy, energetic, joyful. Nothing about the trip hinted that a lethal, almost unheard-of disease was already in motion inside his body.

On the night of July 3, everything shifted. Justin told his parents his stomach hurt. Any parent knows that moment: you weigh whether it is something small, like too much junk food or a minor bug, or something serious. His parents “figured it was something normal,” just as most of us would. The symptoms soon grew worse, and the family went from planning the next day’s activities to searching for urgent medical care in a place far from home.

The race from first symptoms to Randall Children’s Hospital

Doctors first saw what looked like a child with vague complaints and rapidly worsening illness, the kind of confusing picture that fills emergency rooms every night. As tests came back, one physician suspected a rare condition called Clarkson’s disease, also known as systemic capillary leak syndrome. This disorder causes fluid and proteins to leak out of tiny blood vessels into surrounding tissues, dropping blood pressure and swelling organs in ways that can quickly lead to shock and organ failure. In children, published medical reviews say it can follow a viral-like illness and progress to severe complications.

Justin was transferred to Randall Children’s Hospital, a major pediatric center in Portland, where the fight became intense and focused. His parents later told reporters that the shift from “happy and healthy” to saying goodbye in the hospital happened in just a few days. Physicians worldwide know Clarkson’s disease as a medical trap: it often starts with non-specific symptoms like weakness, pain, or stomach issues, then suddenly flips into full-blown shock as plasma pours out of the bloodstream and into tissues. Even in top hospitals, these rapid attacks are hard to recognize in time and even harder to stop once in full swing.

What Clarkson’s disease does inside the body

Clarkson’s disease is a form of systemic capillary leak syndrome where the body’s smallest blood vessels, the capillaries, become abnormally leaky. Plasma, the liquid part of blood, escapes into muscles and organs, leaving the circulation dry and thick. Patients suffer severe low blood pressure, swelling, and damage to organs starved of normal blood flow. Classic signs include hypotension, high red-cell concentration, and low blood protein levels, all pointing to fluids leaving the bloodstream in large amounts.

Worldwide, fewer than about 500 cases of Clarkson’s disease have been described since the 1960s. It usually affects adults in midlife, which makes a fatal case in a 5-year-old even more rare and medically striking. Studies estimate that about one quarter of patients die from attacks of this condition, even with modern intensive care. Some specialized centers use treatments like theophylline, terbutaline, steroids, and monthly intravenous immune globulin infusions to reduce repeat episodes for survivors, but there is no proven cure and no large trials because the disease is so rare.

A rare tragedy and the problem of public risk perception

After Justin’s death on July 7 at Randall Children’s Hospital, local news coverage focused on the shock of “a mysterious disease so rare there are only a few hundred documented cases worldwide.” That reaction fits a wider pattern. Research comparing media coverage to real-world death causes finds that rare, dramatic events often get outsized attention, while common killers like heart disease and diabetes rarely make headlines. People then judge the diseases they hear about most as more common and more serious, even when the opposite is true.

5-Year-Old Dies of Extremely Rare Condition While On Family Vacation

A 5-year-old boy — Justin Vu — died last week from a medical condition so rare, less than 500 cases have ever been diagnosed worldwide.

Justin died July 8 from systemic capillary leak syndrome, also called… pic.twitter.com/noHpHp80Ps

— 7happy (@Sevenhappy007) July 14, 2026

This gap matters for families and for policy. Rare diseases as a group still affect millions of people worldwide, even though each single disease may hit fewer than one in a million. Yet funding, drug trials, and routine pediatric training often lean toward common conditions. The question is not whether the media should ignore tragedies like Justin’s. It is whether we have allowed feel-good awareness campaigns and dramatic stories to replace steady, practical investment in earlier diagnosis and treatment for both rare and common diseases.

Honoring Justin while pushing medicine to do better

Justin’s parents have chosen to share their story in interviews and online fundraisers, both to cover costs and to help other families and doctors recognize Clarkson’s disease faster. This is a common pattern in rare disease communities: grieving families turn private loss into public warnings, spreading awareness and asking for support. Their efforts do not change the hard medical reality that some conditions still outrun our science. But they can push hospitals, researchers, and drug makers to include rare pediatric conditions when they design studies and training.

Clarkson’s disease will likely never be a household term. Most parents will never hear it from a doctor, and most doctors will never see a case in their whole career. Yet for one Oregon vacation, it was the only fact that mattered. A boy with a stomach ache on July 3 died on July 7 from a disease that, until then, lived only in journal articles and scattered case reports. That is the silent weight of rare diseases: they are almost invisible, right up until they change one family’s life forever.